The American Medical Association (AMA) is hosting a webinar series, "COVID-19 Vaccine Development—What Physicians Need to Know."
This vital series addresses the science, evidence, and process of vaccine development, regulatory review, and what physicians need to know. Hosted by AMA physician leaders, each installment aims to gain fact-based insights from the nation’s highest-ranking subject matter experts working to protect the health of the public.
Episode 1: FDA Review Process for COVID-19 Vaccine Candidates
Date: Wednesday, October 7, 2020
Time: 2 p.m. CT/3 p.m. ET
Host: AMA President, Susan R. Bailey, MD
Guest: Peter Marks, MD, PhD, Director of the Center for Biologics Evaluation and Research at the Food and Drug Administration (FDA)
Dr. Bailey and Dr. Marks will give a comprehensive overview of the FDA vaccine review process, including what the process looks like for COVID-19 vaccine candidates and the differences between the Emergency Use Authorization (EUA) and Biologic License Application (BLA) pathways.
Registration information coming soon.